A critical discovery in cancer investigation is arising with the use of VHH fragments to re-engage mutated p53. This essential malignant suppressor protein is frequently inactivated in many forms of tumors, leading https://thesocialintro.com/story7640472/nanobodies-revive-the-p53-protein-new-potential-approach-for-tumor-therapy